24010.rar Apr 2026

: It examines the ability of the mutant proteins to exchange nuclear co-repressors for co-activators, which is a critical factor in how the body responds—or fails to respond—to therapy.

: This specific data (prot.24010) details the molecular consequences of resistance to All-Trans Retinoic Acid (ATRA) , a standard treatment for APL. RAR 24010.rar

oncogene, which is frequently associated with scientific data papers indexed by the code . : It examines the ability of the mutant

: The research tracks how certain mutations (like the L398P variant) affect the protein's breakdown when exposed to ATRA/Arsenic Trioxide (ATO) combination treatments. 24010.rar

Mutations : The study focuses on mutations localized to the RAR

ligand-binding domain (LBD) , which can compromise how well treatments bind to the oncogene.